New Delhi: Dr. Reddy's Laboratories Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed a Pre-License Inspection (PLI) at the company's ...
A June inspection now has the FDA hitting Dr. Reddy’s with a Form 483, with seven observations spotted at its Indian biologics plant in Hyderabad during a site visit that wrapped up this week. The ...
https://www.thehindubusinessline.com/companies/stronger-translational-research-need-of-the-hour-for-indian-pharma-dr-reddys-chairman-satish-reddy/article71140955.ece ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果